Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterized by an exaggerated response of the immune system (a hypersensitivity response) to fungus Aspergillus. Aspergillus-associated pericarditis leading pericardial tamponade rare. In our case, we presented case 22-year-old female asthmatic patient with no other medical conditions who emergency department (ED) complaining sever...

<b>Hintergrund:</b> Die Lockdown-Phasen während der anhaltenden Coronavirus-Pandemie mit Erkrankung COVID-19 haben die Art und Weise verändert, wie Personen Gemeinschaften leben, arbeiten interagieren. <b>Fallvorstellung:</b> Der vorliegende Fallbericht beschreibt eine ungewöhnliche, aber bedeutende Manifestationsform allergischen bronchopulmonalen Aspergillose (ABPA) be...

Allergic bronchopulmonary aspergillosis (ABPA) is most frequently seen in patients suffering from allergic asthma (1). In spite of itraconazole, some patients experience recurrent exacerbations or require long term intensive treatment (steroids) (2). The presence of high levels of IgE, the presence of an often difficult to treat asthma, as well as recent data on the favourable results of the ad...

The Aspergillus nidulans endocytic internalization protein SlaB is essential, in agreement with the key role in apical extension attributed to endocytosis. We constructed, by gene replacement, a nitrate-inducible, ammonium-repressible slaB1 allele for conditional SlaB expression. Video microscopy showed that repressed slaB1 cells are able to establish but unable to maintain a stable polarity ax...

Allergic bronchopulmonary aspergillosis (ABPA) is caused by colonisation of the lungs with Aspergillus fumigatus resulting in a hypersensitivity reaction and bronchiectasis. Allergic asper-gillus sinusitis (AAS) has similar histopathological features and yet simultaneous occurrence is rarely reported. We report a case of an aspergilloma in the paranasal sinuses causing unilateral blindness with...

Rationale and objectives. Severe asthma with fungal sensitization (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) are progressive allergic fungal lung diseases whose effective treatment remains to be established. Current treatment with itraconazole is associated with a 40% failure rate and adverse events (AEs). We assessed the effect of voriconazole or posaconazole as second- and thir...